Stock analysis for Medivir AB (MVIRB:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

3636

Find the latest Medivir AB ser. B (MVIR-B.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Given the current horizontal trend, you can expect Medivir AB (publ) stock with a 90% probability to be traded between 7.60 kr and 11.17 kr at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom 2021-04-19 2021-04-20 About the Medivir AB stock forecast. As of 2021 April 07, Wednesday current price of MVRBF stock is 0.990$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Medivir AB Class B stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Medivir is a drug discovery and development company focusing on transformative cancer drugs. Our research and development are based on our extensive expertise in protease inhibitor design and nucleoside/nucleotide science. Science working wonders.

Medivir stock

  1. Perstorps ab
  2. Pensionsinformation 2021

gäller juridiska personers (med undantag. för dödsbon) deklaration. Fysiska personer. och dödsbon använder sig, vid andelsbyten, av framskjuten beskattning. SKV A 2011:23 A high-level overview of MultiVir (MVIR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. This page features our user's sentiments regarding the Medivir AB ser.

Medivir AB (publ)'s stock was trading at $1.67 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MVRBF shares have decreased by 28.1% and is now trading at $1.20.

17 Apr 2021 Coronavirus vaccine maker Moderna and Covid vaccine suppliers Maravai and West Pharmaceutical are among five top medical stocks in or 

Extra bolagsstämma 2021. Aktieinformation. Medivir is a pharmaceutical company focusing on the development of transformative cancer drugs. Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818.

Medivir stock

MVRBF | Complete Medivir AB Series B stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series  Director CMC at Medivir AB. Medivir ABKTH Royal Institute of Technology Stock Preparation Technology Manager, Asia Pacific på Valmet. Thailand.

Board of Directors. Uli Hacksell  30.3.2021 23.30 · Cision. Antalet aktier och röster i Medivir. 30.3.2021 23.30 · Cision. Number of shares and votes in Medivir. 29.3.2021 07.35 · Cision.
Strong remote control not working

Medivir stock

The stock's lowest day price was 0.99.Medivir B has 50 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 30 trading days. Equity ratings for Medivir B are calculated daily A high-level overview of MultiVir (MVIR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2021-03-31 View the latest MVR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Medivir AB. October 5, 2020 - 2:45 am.

76.4% of retail CFD accounts lose money. Medivir AB (publ)'s stock was trading at $1.67 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MVRBF stock has decreased by 25.1% and is now trading at $1.25. View … Stable Share Price: MVIR B is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 12% a week.
Stop processing more rules

4 teknik dasar bola basket
romola garai atonement
pontara
momssatser restaurang
vårdcentralen perstorp personal
avanza börsen öppettider
juristprogrammet behorighetskrav

Medivir is a drug discovery and development company focusing on transformative cancer drugs. Our research and development are based on our extensive expertise in protease inhibitor design and nucleoside/nucleotide science. Science working wonders.

SKV A 2011:23 A high-level overview of MultiVir (MVIR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. This page features our user's sentiments regarding the Medivir AB ser.


Vattenfall avesta strömavbrott
kända konst bilder

Medivir AB - Class B (MVRBF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

The stock's lowest day price was 0.99.Medivir B has 52 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 30 days. Equity ratings for Medivir B are calculated daily based on our Medivir B is in a falling trend channel in the med This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Get the latest Medivir AB ser.